21.95 USD
+0.03 (+0.14%)
At close: Feb 6, 2026
21.95 USD
0 (0%)
After Hours: 2/6/2026, 8:00:20 PM
Taking everything into account, PGNY scores 7 out of 10 in our fundamental rating. PGNY was compared to 102 industry peers in the Health Care Providers & Services industry. PGNY has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. PGNY is growing strongly while it is still valued neutral. This is a good combination! These ratings could make PGNY a good candidate for growth and quality investing.
1. Profitability
1.1 Basic Checks
- PGNY had positive earnings in the past year.
- In the past year PGNY had a positive cash flow from operations.
- Each year in the past 5 years PGNY has been profitable.
- Each year in the past 5 years PGNY had a positive operating cash flow.
1.2 Ratios
- The Return On Assets of PGNY (7.11%) is better than 88.24% of its industry peers.
- PGNY has a Return On Equity of 10.10%. This is in the better half of the industry: PGNY outperforms 71.57% of its industry peers.
- With an excellent Return On Invested Capital value of 11.24%, PGNY belongs to the best of the industry, outperforming 83.33% of the companies in the same industry.
- PGNY had an Average Return On Invested Capital over the past 3 years of 8.25%. This is in line with the industry average of 9.16%.
- The last Return On Invested Capital (11.24%) for PGNY is above the 3 year average (8.25%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 7.11% | ||
| ROE | 10.1% | ||
| ROIC | 11.24% |
ROA(3y)7.58%
ROA(5y)11.89%
ROE(3y)10.72%
ROE(5y)17.23%
ROIC(3y)8.25%
ROIC(5y)7.66%
1.3 Margins
- The Profit Margin of PGNY (4.46%) is better than 77.45% of its industry peers.
- PGNY's Profit Margin has declined in the last couple of years.
- PGNY has a better Operating Margin (6.77%) than 70.59% of its industry peers.
- In the last couple of years the Operating Margin of PGNY has grown nicely.
- PGNY has a Gross Margin of 22.94%. This is comparable to the rest of the industry: PGNY outperforms 48.04% of its industry peers.
- PGNY's Gross Margin has improved in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 6.77% | ||
| PM (TTM) | 4.46% | ||
| GM | 22.94% |
OM growth 3Y-3.61%
OM growth 5Y1.87%
PM growth 3Y-29.25%
PM growth 5YN/A
GM growth 3Y-1.03%
GM growth 5Y1.85%
2. Health
2.1 Basic Checks
- PGNY has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
- Compared to 1 year ago, PGNY has less shares outstanding
- Compared to 5 years ago, PGNY has more shares outstanding
- There is no outstanding debt for PGNY. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
2.2 Solvency
- An Altman-Z score of 7.73 indicates that PGNY is not in any danger for bankruptcy at the moment.
- The Altman-Z score of PGNY (7.73) is better than 94.12% of its industry peers.
- PGNY has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Altman-Z | 7.73 |
ROIC/WACC1.27
WACC8.86%
2.3 Liquidity
- A Current Ratio of 2.96 indicates that PGNY has no problem at all paying its short term obligations.
- Looking at the Current ratio, with a value of 2.96, PGNY belongs to the top of the industry, outperforming 83.33% of the companies in the same industry.
- PGNY has a Quick Ratio of 2.96. This indicates that PGNY is financially healthy and has no problem in meeting its short term obligations.
- PGNY has a better Quick ratio (2.96) than 83.33% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.96 | ||
| Quick Ratio | 2.96 |
3. Growth
3.1 Past
- The Earnings Per Share has grown by an nice 8.62% over the past year.
- PGNY shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -4.77% yearly.
- Looking at the last year, PGNY shows a quite strong growth in Revenue. The Revenue has grown by 11.41% in the last year.
- Measured over the past years, PGNY shows a very strong growth in Revenue. The Revenue has been growing by 38.42% on average per year.
EPS 1Y (TTM)8.62%
EPS 3Y-4.77%
EPS 5YN/A
EPS Q2Q%36.36%
Revenue 1Y (TTM)11.41%
Revenue growth 3Y32.6%
Revenue growth 5Y38.42%
Sales Q2Q%9.32%
3.2 Future
- The Earnings Per Share is expected to grow by 32.94% on average over the next years. This is a very strong growth
- PGNY is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 8.83% yearly.
EPS Next Y17.75%
EPS Next 2Y29.28%
EPS Next 3Y26.74%
EPS Next 5Y32.94%
Revenue Next Year11.37%
Revenue Next 2Y10.44%
Revenue Next 3Y10.6%
Revenue Next 5Y8.83%
3.3 Evolution
- The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
- The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
- Based on the Price/Earnings ratio of 34.84, the valuation of PGNY can be described as expensive.
- PGNY's Price/Earnings ratio is in line with the industry average.
- Compared to an average S&P500 Price/Earnings ratio of 27.93, PGNY is valued a bit more expensive.
- Based on the Price/Forward Earnings ratio of 23.04, the valuation of PGNY can be described as rather expensive.
- PGNY's Price/Forward Earnings is on the same level as the industry average.
- The average S&P500 Price/Forward Earnings ratio is at 27.77. PGNY is around the same levels.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 34.84 | ||
| Fwd PE | 23.04 |
4.2 Price Multiples
- PGNY's Enterprise Value to EBITDA ratio is in line with the industry average.
- Compared to the rest of the industry, the Price/Free Cash Flow ratio of PGNY indicates a rather cheap valuation: PGNY is cheaper than 85.29% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 9.78 | ||
| EV/EBITDA | 14.8 |
4.3 Compensation for Growth
- The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
- PGNY has a very decent profitability rating, which may justify a higher PE ratio.
- PGNY's earnings are expected to grow with 26.74% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.96
PEG (5Y)N/A
EPS Next 2Y29.28%
EPS Next 3Y26.74%
5. Dividend
5.1 Amount
- No dividends for PGNY!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
21.95
+0.03 (+0.14%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)11-06 2025-11-06/amc
Earnings (Next)03-02 2026-03-02/amc
Inst Owners104.67%
Inst Owner Change-2.18%
Ins Owners1.48%
Ins Owner Change0.5%
Market Cap1.89B
Revenue(TTM)1.27B
Net Income(TTM)56.57M
Analysts81.18
Price Target30.79 (40.27%)
Short Float %4.61%
Short Ratio2.57
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)14.43%
Min EPS beat(2)14.22%
Max EPS beat(2)14.63%
EPS beat(4)3
Avg EPS beat(4)8.02%
Min EPS beat(4)-11.77%
Max EPS beat(4)15%
EPS beat(8)5
Avg EPS beat(8)7.07%
EPS beat(12)9
Avg EPS beat(12)35.08%
EPS beat(16)13
Avg EPS beat(16)94.29%
Revenue beat(2)2
Avg Revenue beat(2)2.31%
Min Revenue beat(2)1.96%
Max Revenue beat(2)2.66%
Revenue beat(4)4
Avg Revenue beat(4)3.39%
Min Revenue beat(4)1.96%
Max Revenue beat(4)5.74%
Revenue beat(8)4
Avg Revenue beat(8)-0.43%
Revenue beat(12)7
Avg Revenue beat(12)0.39%
Revenue beat(16)9
Avg Revenue beat(16)-0.09%
PT rev (1m)3.72%
PT rev (3m)5.11%
EPS NQ rev (1m)0%
EPS NQ rev (3m)6.42%
EPS NY rev (1m)0%
EPS NY rev (3m)6.34%
Revenue NQ rev (1m)0.47%
Revenue NQ rev (3m)1.24%
Revenue NY rev (1m)0.08%
Revenue NY rev (3m)1.48%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 34.84 | ||
| Fwd PE | 23.04 | ||
| P/S | 1.49 | ||
| P/FCF | 9.78 | ||
| P/OCF | 9.09 | ||
| P/B | 3.38 | ||
| P/tB | 3.55 | ||
| EV/EBITDA | 14.8 |
EPS(TTM)0.63
EY2.87%
EPS(NY)0.95
Fwd EY4.34%
FCF(TTM)2.24
FCFY10.22%
OCF(TTM)2.41
OCFY11%
SpS14.72
BVpS6.5
TBVpS6.19
PEG (NY)1.96
PEG (5Y)N/A
Graham Number9.6
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 7.11% | ||
| ROE | 10.1% | ||
| ROCE | 14.68% | ||
| ROIC | 11.24% | ||
| ROICexc | 27.43% | ||
| ROICexgc | 30.82% | ||
| OM | 6.77% | ||
| PM (TTM) | 4.46% | ||
| GM | 22.94% | ||
| FCFM | 15.25% |
ROA(3y)7.58%
ROA(5y)11.89%
ROE(3y)10.72%
ROE(5y)17.23%
ROIC(3y)8.25%
ROIC(5y)7.66%
ROICexc(3y)19.18%
ROICexc(5y)17.15%
ROICexgc(3y)20.6%
ROICexgc(5y)18.86%
ROCE(3y)10.79%
ROCE(5y)10.01%
ROICexgc growth 3Y11.16%
ROICexgc growth 5Y-10.91%
ROICexc growth 3Y11.54%
ROICexc growth 5Y-2.19%
OM growth 3Y-3.61%
OM growth 5Y1.87%
PM growth 3Y-29.25%
PM growth 5YN/A
GM growth 3Y-1.03%
GM growth 5Y1.85%
F-Score7
Asset Turnover1.6
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Debt/EBITDA | 0 | ||
| Cap/Depr | 330.21% | ||
| Cap/Sales | 1.16% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 230.54% | ||
| Profit Quality | 342.01% | ||
| Current Ratio | 2.96 | ||
| Quick Ratio | 2.96 | ||
| Altman-Z | 7.73 |
F-Score7
WACC8.86%
ROIC/WACC1.27
Cap/Depr(3y)177.5%
Cap/Depr(5y)150.16%
Cap/Sales(3y)0.4%
Cap/Sales(5y)0.39%
Profit Quality(3y)290.66%
Profit Quality(5y)196.79%
High Growth Momentum
Growth
EPS 1Y (TTM)8.62%
EPS 3Y-4.77%
EPS 5YN/A
EPS Q2Q%36.36%
EPS Next Y17.75%
EPS Next 2Y29.28%
EPS Next 3Y26.74%
EPS Next 5Y32.94%
Revenue 1Y (TTM)11.41%
Revenue growth 3Y32.6%
Revenue growth 5Y38.42%
Sales Q2Q%9.32%
Revenue Next Year11.37%
Revenue Next 2Y10.44%
Revenue Next 3Y10.6%
Revenue Next 5Y8.83%
EBIT growth 1Y31.12%
EBIT growth 3Y27.82%
EBIT growth 5Y41.01%
EBIT Next Year40.11%
EBIT Next 3Y20.4%
EBIT Next 5Y15.66%
FCF growth 1Y-2.78%
FCF growth 3Y93.67%
FCF growth 5YN/A
OCF growth 1Y2.69%
OCF growth 3Y90.18%
OCF growth 5YN/A
PROGYNY INC / PGNY FAQ
What is the fundamental rating for PGNY stock?
ChartMill assigns a fundamental rating of 7 / 10 to PGNY.
Can you provide the valuation status for PROGYNY INC?
ChartMill assigns a valuation rating of 4 / 10 to PROGYNY INC (PGNY). This can be considered as Fairly Valued.
How profitable is PROGYNY INC (PGNY) stock?
PROGYNY INC (PGNY) has a profitability rating of 7 / 10.
What is the earnings growth outlook for PROGYNY INC?
The Earnings per Share (EPS) of PROGYNY INC (PGNY) is expected to grow by 17.75% in the next year.